NME5 and breast carcinoma: To test this hypothesis, we evaluated the prognostic potential of 16 putative prognostic biomarkers (AZGP1, BTG2, CBX2, CNTNAP2, DNALI1, LOC389033, NME5, PIP, S100A8, SCUBE2, SERPINA11, STC2, STK32B, SUSD3, UBE2C, and WHSC1L1) previously identified in breast carcinoma using oral squamous cell carcinoma [14,15].